CIBC Asset Management
KRTX

CIBC Asset Management’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

CIBC Asset Management’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-801
Closed -$254K – 1160
2023
Q4 		$254K Buy
+801
New +$156K ﹤0.01% 878
2022
Q4 		– Sell
-1,211
Closed -$272K – 1287
2022
Q3 		$272K Buy
+1,211
New +$245K ﹤0.01% 927

Other funds holding KRTX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

CIBC Asset Management's KRTX Position: Q1 2024 in Review

CIBC Asset Management sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 801 shares — an estimated $254K sold.

CIBC Asset Management first reported a position in KRTX in Q3 2022 and held it in 2 quarters. The position peaked at $272K in Q3 2022. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

  • CIBC Asset Management reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • CIBC Asset Management sold 801 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $254K.
  • CIBC Asset Management first reported a position in Karuna Therapeutics, Inc. Common Stock in Q3 2022 and held it in 2 quarters.
  • CIBC Asset Management's Karuna Therapeutics, Inc. Common Stock position peaked at $272K in Q3 2022.
  • 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on CIBC Asset Management's 13F filing for Q1 2024, filed 9 May 2024.